Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Cantor Fitzgerald
Harvard Business School
Dow
Argus Health
Chubb
Colorcon
US Army
Teva

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088195

« Back to Dashboard

NDA 088195 describes HYDROFLUMETHIAZIDE AND RESERPINE, which is a drug marketed by Usl Pharma and Watson Labs and is included in three NDAs. Additional details are available on the HYDROFLUMETHIAZIDE AND RESERPINE profile page.

The generic ingredient in HYDROFLUMETHIAZIDE AND RESERPINE is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
Summary for 088195
Tradename:HYDROFLUMETHIAZIDE AND RESERPINE
Applicant:Usl Pharma
Ingredient:hydroflumethiazide; reserpine
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG;0.125MG
Approval Date:Oct 26, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Merck
Argus Health
McKesson
Fuji
Daiichi Sankyo
Baxter
QuintilesIMS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.